Alcon announces U.S. roll out of TRYPTYR, a new prescription treatment option for millions of dry eye sufferers
TRYPTYR is a first-in-class TRPM8 receptor agonist for the treatment of the signs and symptoms of Dry Eye Disease (DED) that rapidly stimulates natural tear production as early as Day 1.